| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |